Review: Long-term lithium treatment lowers suicide risk in major affective disorder

Burgess, Sally
March 2002
ACP Journal Club;Mar/Apr2002, Vol. 136 Issue 2, p63
Academic Journal
Focuses on a study which investigated the association of long-term lithium treatment with lower-suicide risk in patients with a major affective disorder. Methodology of the study; Results; Comments on the study.


Related Articles

  • Lithium: proving its mettle for 50 years. Friedrich, M.J. // JAMA: Journal of the American Medical Association;6/23/99, Vol. 281 Issue 24, p2271 

    Discusses 50 years of lithium's medical usefulness. Claims for lithium's healing powers in the late 1800s and early 1900s; Mention of paper published by Australian psychiatrist John Cade in 1949; Details about a study by Dr. Paul Grof et al of patients shown to be excellent responders to...

  • Does lithium save lives? Joffe, Russell T. // Journal of Psychiatry & Neuroscience;Jan2004, Vol. 29 Issue 1, p9 

    Provides information on the antisuicide effect of lithium. Advantage of lithium over divalproex in the treatment of bipolar disorder; Use of lithium as treatment for bipolar disorder; Impact of lithium on suicidal behavior.

  • [Commentary on] Review: lithium reduces the risk of suicide compared with placebo in people with depression and bipolar disorder. Cipriani, Andrea; Young, Allan H. // Evidence Based Mental Health;Nov2013, Vol. 16 Issue 4, p112 

    The article discusses the effectiveness of lithium in preventing suicide and self-harm among people with unipolar depression and bipolar disorder, which was the topic of the review conducted by A. Cipriani and colleagues on randomised controlled trials (RCT) available in MEDLINE, EMBASE, CINAHL...

  • Personal View. Jameson, Richard // British Medical Journal (Clinical Research Edition);8/24/1985, Vol. 291 Issue 6495, p541 

    Comments on the disorder schizophrenia. Association of schizophrenia to violent mood swings; Definition of the disorder; Consideration as traumatic experience of hospital visit by patients; Suggestions in management of patients; Attitude of the patients suffering the disorder.

  • Lithium intoxication. Guddant, J.; Frackowisk, R.S.J.; Pusey, C.D.; MacDermot, J.; Macbeth, P.F. Liddle; Winter, Robert // BMJ: British Medical Journal (International Edition);5/25/91, Vol. 302 Issue 6787, p1267 

    Presents a case study of a patient intoxicated by lithium in Great Britain. Usage of lithium carbonate for the treatment of bipolar affective disorders; Symptoms of lithium intoxication; Management of acute and chronic intoxication.

  • Preliminary assessment of intrahemispheric QEEG measures in bipolar mood disorders. Oluboka, OJ; Stewart, SL; Sharma, V; Mazmanian, D; Persad, E; Oluboka, O J; Stewart, S L // Canadian Journal of Psychiatry;May2002, Vol. 47 Issue 4, p368 

    Objective: This study assessed the quantitative electroenchephalographic (QEEG) absolute power and coherence differences between a group of patients with bipolar I mood disorder (BMD I) and a group of patients with schizophrenia. We also examined the correlation between QEEG...

  • Suicide Prevention, Recurrent Affective Disorder and Lithium. Barraclough, Brian // British Journal of Psychiatry;Oct72, Vol. 121 Issue 563, p391 

    The article discusses the research which examines the clinical state and past histories of 100 cases of suicide and establishes the proportion of recurrent depressives who might respond to lithium. The study was concerned with those suicides who had an established recurrent affective illness....

  • Basic parameters of saccadic eye movements � differences between unmedicated schizophrenia and affective disorder patients. Mahlberg, Richard; Steinacher, Bruno; Mackert, Arthur; Flechtner, Klaus-Malte // European Archives of Psychiatry & Clinical Neuroscience;2001, Vol. 251 Issue 5, p205 

    Background Smooth pursuit eye movement (SPEM) dysfunctions are considered a biological marker for schizophrenia and have been studied widely. In contrast, saccadic eye movements have received less attention, although disturbances have been described previously. Basic neurophysiologic parameters...

  • Olanzapine in Schizophrenia and Affective Disorders. Undurraga, Juan; Vieta, Eduard; Tohen, Mauricio; Colom, Francesc // Drug Safety;2012, Vol. 35 Issue 12, p1185 

    A letter to the editor is presented in response to the article on a meta-analysis on the application of the olanzapine drug to patients with schizophrenia and affective disorders.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics